BDNF-TrkB Signaling in Mitochondria: Implications for Neurodegenerative Diseases
Molecular Neurobiology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 19, 2024
Language: Английский
Intermittent fasting and neurocognitive disorders: What the evidence shows
J. M. R. Beveridge,
No information about this author
A.M.J. Montgomery,
No information about this author
George T. Grossberg
No information about this author
et al.
The journal of nutrition health & aging,
Journal Year:
2025,
Volume and Issue:
29(4), P. 100480 - 100480
Published: Jan. 10, 2025
Language: Английский
Plasma Metabolites as Mediators Between Gut Microbiota and Parkinson’s Disease: Insights from Mendelian Randomization
Jianzhun Chen,
No information about this author
Liuhui Zhu,
No information about this author
Fang Wang
No information about this author
et al.
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 17, 2025
Language: Английский
Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders
Alka Ashok Singh,
No information about this author
Sadhana Katiyar,
No information about this author
Minseok Song
No information about this author
et al.
Brain Sciences,
Journal Year:
2025,
Volume and Issue:
15(3), P. 252 - 252
Published: Feb. 27, 2025
Neurological
disorders
are
defined
by
a
deterioration
or
disruption
of
the
nervous
system’s
structure
and
function.
These
diseases,
which
include
multiple
sclerosis,
Alzheimer’s
disease,
Parkinson’s
Huntington’s
schizophrenia,
caused
intricate
pathological
processes
that
excitotoxicity,
neuroinflammation,
oxidative
stress,
genetic
mutations,
compromised
neurotrophic
signaling.
Although
current
pharmaceutical
treatments
relieve
symptoms,
their
long-term
efficacy
is
limited
due
to
adverse
side
effects
weak
neuroprotective
properties.
However,
when
combined
with
other
drugs
adjunct
therapy,
they
may
offer
additional
benefits
improve
treatment
outcomes.
Phytochemicals
have
emerged
as
attractive
therapeutic
agents
ability
regulate
essential
pathways,
especially
brain-derived
factor
(BDNF)
signaling
cascade.
BDNF
an
important
target
for
neurodegenerative
disease
(ND)
since
it
regulates
neuronal
survival,
synaptic
plasticity,
neurogenesis,
neuroprotection.
This
review
emphasizes
molecular
pathways
through
various
phytochemicals—such
flavonoids,
terpenoids,
alkaloids,
phenolic
compounds—stimulate
expression
modulate
its
downstream
including
GSK-3β,
MAPK/ERK,
PI3K/Akt/mTOR,
CREB,
Wnt/β-catenin.
paper
also
highlights
how
phytochemical
combinations
interact
enhance
activity,
offering
new
options
ND
treatment.
Despite
potential
neuroprotection,
phytochemicals
face
challenges
related
pharmacokinetics,
blood–brain
barrier
(BBB)
permeability,
absorption,
highlighting
need
further
research
into
combination
therapies
improved
formulations.
Clinical
assessment
mechanistic
understanding
BDNF-targeted
phytotherapy
should
be
main
goals
future
studies.
The
natural
compounds
in
regulating
highlighted
this
review,
providing
viable
approach
prevention
NDs.
Language: Английский
Deciphering the Neuroprotective Action of Bee Venom Peptide Melittin: Insights into Mechanistic Interplay
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
Language: Английский
Neurotrophic Effects of Foeniculum vulgare Ethanol Extracts on Hippocampal Neurons: Role of Anethole in Neurite Outgrowth and Synaptic Development
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12701 - 12701
Published: Nov. 26, 2024
Foeniculum
vulgare
Mill,
commonly
known
as
fennel,
is
an
aromatic
herb
traditionally
used
for
culinary
and
medicinal
purposes,
with
potential
therapeutic
effects
on
neurological
disorders.
However,
limited
research
has
focused
its
neurotrophic
impact,
particularly
neuronal
maturation
synaptic
development.
This
study
investigates
the
of
F.
ethanol
extracts
(FVSE)
rat
primary
hippocampal
neurons.
Results
show
that
FVSE
prominent
component,
anethole,
significantly
promote
neurite
outgrowth
in
a
dose-dependent
manner.
Optimal
axonal
dendritic
growth
occurred
at
concentrations
40
µg/mL
20
µM
respectively,
without
causing
cytotoxicity,
underscoring
safety
health.
Additionally,
enhances
formation
synapses,
essential
communication.
Network
pharmacology
analysis
revealed
components
influence
critical
pathways,
including
PI3K-AKT
Alzheimer’s
disease
pathways.
Specifically,
modulates
key
proteins,
tropomyosin
receptor
kinase
(Trk),
glycogen
synthase
3
(GSK3βser9),
phosphatidylinositol
3-kinase
(PI3K),
extracellular
signal-regulated
protein
(Erk1/2).
Anethole
was
found
to
play
role
regulating
these
which
confirmed
by
immunocytochemistry
experiments
demonstrating
effect
promoting
In
conclusion,
this
highlights
properties
FVSE,
anethole
emerging
bioactive
compound.
These
findings
provide
valuable
insights
into
fennel
treating
disorders,
offering
basis
future
interventions
survival.
Language: Английский